Mathew et al. Combination biologics from MarketScan. Combination less likely to have ER visit in 180 days 17% vs 23% @RheumNow #ACR22 Abstr#0768 https://t.co/Y880qDXMow https://t.co/gOH2Zlt6UV
Links:
Reevaluating Clinical Outcomes of Patients on Combination Biologics - ACR Meeti…
https://acrabstracts.org/abstract/reevaluating-clinical-outcomes-of-patients-on…
13-11-2022
